Investor relations
AIM Rule 26
In accordance with AIM Rule 26, as stipulated by the London Stock Exchange, all AIM-quoted companies are required to disclose certain information on their corporate website.
In compliance with this rule, Angel Biotech plc (registered in London no: 05383314) has provided the following information on this site.
Angel Biotechnology Holdings Plc's AIM Admission document PDF (322KB).
Annual and interim reports
Articles of Association
Business description
Board of Directors' biographies
Company advisors
Directors' responsibilities
Major shareholders
Notifications
Contact us
for investor relations queries:
Lorna Peers
Finance Director and Company Secretary
Tel:+44 (0)131 4456077
enquiries@angelbio.com
Our services
Along with the successful production of recombinants, Angel provides development and process scale-up strategies
